Impact of procedural and patient-related risks on 1-year outcomes for patients with 1-month DAPT followed by P2Y12 inhibitor monotherapy after biodegradable-polymer drug-eluting stent implantation
30 August 2024 (08:00 - 17:30)
Organised by: 

About the speaker

Yahaba (Japan)
7 More presentations in this session

Assistant Professor D. Hyun (Kwang Ju, KR)

Doctor D. Mutschlechner (Mistelbach, AT)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
You may be interested in
Congress Presentation



